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Abstract
Background: Excavated pulmonary metastasis are rare. We present two cases of excavated pulmonary nodules proved 
to be metastases from osteosarcoma and gallblader lymphoma.
Case presentation: The first one is 39-year-old man in whom cholecystectomy made the diagnosis of primary non-
Hodgkin's lymphoma of the gallbladder. He presented in chest CT scan excavated nodules that had been biopsied and 
confirmed the diagnosis of non hodgkin lymphoma. He underwent 8 courses of chemotherapy CHOP 21 with 
complete remission. The second one is an 21 years old man who presented a right leg osteoblastic osteosarcoma with 
only excavated pulmonary nodules in extension assessment. He had 3 courses of polychemotherapy API (doxorubicin, 
platinum, and ifosfamide) with partial response. Unfortunately, he died following a septic shock.
Review of the literature shows that excavated pulmonary nodules as metastasis are rare but we should consider this 
diagnosis every time we are in front of a cancer. Chest computed tomography is the best diagnosis imaging that could 
make this diagnosis. Differential diagnosis between benign and malignant bullous lesions is important because 
surgical excision affects survival in some malignancies.
Conclusions: Although pulmonary nodules are the most common cancer metastasis, a differential diagnosis of a 
concurrent primary malignancy should always be considered every time we have excavated lesions, even in patients 
with known malignant disease. Thorough chest evaluation is important, as multiple primary malignancies may occur 
concomitantly.
Background
Metastatic causes of excavated pulmonary nodules are
rare but must be considered in patients with a history of
neoplastic disease.
Excavated metastatic pulmonary lesions are described,
but in a country of epidemic tuberculosis, or in front of
smokers, it is necessary to raise differential diagnosis.
Sometimes, chest scann permitt to elaborate a definite
diagnosis, and sometimes, we must resort to a biopsy. We
report here two cases of excavated pulmonary metastasis
attendant to primary malignancies.
Case presentation
Case 1
A 39 year old male with no significant past medical his-
tory, initially presented with a several month history of
intermittent pain localized to the abdominal right upper
quadrant. Our patient was a chronical smoker. He has
consulted and a physical examination revealed multiple
infracentimetric cervical lymphadenopathy. He under-
went an abdominal US which was abnormal (stones
within gallbaldder) and was scheduled for a cholecystec-
tomy. Histopathology from his surgically removed gall-
bladder was consistent with a primary NHL T cell.
Immunostaining showed a positive marking for CD45,
CD3. He underwent further lymphoma staging including
a computed tomography scans of the body which
revealed lymph nodes with surrenal nodules and pulmo-
nary excavated lesions (figure 1). Our patient did a bron-
choscopy to confirm weither the pulmounary nodules
were in relation with the NHL or a pulmnonary disease or
infection such as tubeculosis and concluded to bud of the
stem bronchus that was histologically a lymphoma with
large cell (figure 2). All the biopsies confirmed the nature
of NHL. Bone marrow bio-sy was normal. Left ventricu-
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mal, except a higher rate of LDH that was 754 UI/L.
According to the Ann Arbor's classification, he was
staged IVBb. He underwent treatement by CHOP 21
(cyclophosphamide 750 mg/m2 Intraveinously (IV) day 1,
doxorubicine 50 mg IV day 1, vincristine 1,4 mg/m2 IV
day 1 and prednisone 40 mg/m2 per day from day 1 to day
5 per os, each cycle every 21 days). He was in uncertain
complete response (more than 80% according to Cheson
criteria) after 4cycles and had 8 cycles of CHOP 21 with a
complete response. The patient tolerated chemotherapy
well and he is currently free of disease 12 months after
completion of chemotherapy and 15 months from diag-
nosis. Response was achieved by CT scan (figure 3).
Case 2
A 21 years old man, with no particular medical history,
who presented a right leg painful mass was consulting at
our hospital. There was no history of trauma or infection.
On examination, a great warm mass measuring 12 × 21
cm was found at the end of the right tibia. Signs of
inflammation were observed with a large swelling and
oozing. He had no lymphadenopathy and no other mass.
He just accused intermittent cough lasting for two
months. His blood parameters were correct. An MRI
(magnetic resonnance) was performed to establish the
nature of this mass and its locoregional reports, it objec-
tived abnormal signal intensities with a cortical destruc-
tion. A biopsy was then realised and the histopathological
study revealed a chondroblastic osteosarcoma with an
hypercellular neoplasm. He underwent an extension
assessement by chest CT scan, scintigraphy, that revealed
bilateral excavated pulmonary metastasis with different
sizes and location. A pulmonary biopsy was performed to
eliminate infectious diagnosis or vascularite, and revealed
a metastasis of osteosarcoma. He had 3 courses of poly-
chemotherapy API (doxorubicin 60 mg/m2 IV day 1, cis-
platinum 75 mg/m2 IV day 1, and ifosfamide 7 g/m2 from
day 1 to 5 IV with uromitexan to protect against hemor-
rhagic cystitis ) with partial response. Unfortunately, he
died following a septic shock.
Discussion
Lung represents a major metastatic site of the body as
there's a seat about 30 to 50% of all secondary locations.
Figure 1 Excavated lesions with clear limits and irregular thick-
ened wall before chemotherapy.
 
Figure 2 photograph with a magnification × 100 showing a large 
cell lymphoma proliferation
Figure 3 Disappearance of lesions after chemotherapy.
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observed only in 4% of cases (1). We report two cases
with rare lymphoma of the gallbladder and osteosarcoma
of the leg with pulmonary excavated metastasis empha-
sizing the role of CT in characterizing these lesions.
Primitive tumor corresponds mainly to squamous cell
carcinoma of the head and neck or cervix, rarely to colon
(2,3). Metastatic sarcomas, especially osteogenic can dis-
seminate as excavated pulmonary nodules with a high
risk of pneumothorax. Excavation sometimes occurs after
chemo-radiotherapy (4). A review of litterature shows
that the primary site that metastasis to lung are excavated
are bladder, kidney, breast, and ovary (2,5,6). CT scan is
more sensitive than standard chest radiography for the
detection of excavated metastatic lesions. It also allows
aetiological diagnosis achieved by biopsy guided by the
scan, as in our second observation.
Conclusion
In conclusion, we recommend to realise chest CT scan
and biopsy each suspected lesions to ensure diagnosis of
metastasis.
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